These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 28976981)

  • 1. The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania.
    Gass KM; Sime H; Mwingira UJ; Nshala A; Chikawe M; Pelletreau S; Barbre KA; Deming MS; Rebollo MP
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005944. PubMed ID: 28976981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a confirmatory mapping tool for Lymphatic filariasis endemicity classification in areas where transmission was uncertain in Ethiopia.
    Sime H; Gass KM; Mekasha S; Assefa A; Woyessa A; Shafi O; Meribo K; Kebede B; Ogoussan K; Pelletreau S; Bockarie MJ; Kebede A; Rebollo MP
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006325. PubMed ID: 29579038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shrinking the Lymphatic Filariasis Map of Ethiopia: Reassessing the Population at Risk through Nationwide Mapping.
    Rebollo MP; Sime H; Assefa A; Cano J; Deribe K; Gonzalez-Escalada A; Shafi O; Davey G; Brooker SJ; Kebede A; Bockarie MJ
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004172. PubMed ID: 26539700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
    Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
    Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mini-TAS as a confirmatory mapping tool for remapping areas with uncertain filarial endemicity to exclude/ include for mass drug administration: A report from field validation in India.
    Panda BB; Krishnamoorthy K; Das A; Jain HK; Dixit S; Rahi M; Somalkar N; Mohanty S; Pati S; Ranjit M; Bal M
    PLoS One; 2023; 18(11):e0293641. PubMed ID: 37922274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination.
    Nana-Djeunga HC; Tchatchueng-Mbougua JB; Bopda J; Mbickmen-Tchana S; Elong-Kana N; Nnomzo'o E; Akame J; Tarini A; Zhang Y; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2015; 9(9):e0004001. PubMed ID: 26353087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria bancrofti antigenaemia in and around onchocerciasis endemic areas.
    Shiferaw W; Kebede T; Graves PM; Golasa L; Gebre T; Mosher AW; Tadesse A; Sime H; Lambiyo T; Panicker KN; Richards FO; Hailu A
    Trans R Soc Trop Med Hyg; 2012 Feb; 106(2):117-27. PubMed ID: 22154976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brugia Rapid™ antibody responses in communities of Indonesia in relation to the results of 'transmission assessment surveys' (TAS) for the lymphatic filariasis elimination program.
    Dewi RM; Tuti S; Ganefa S; Anwar C; Larasati R; Ariyanti E; Herjati H; Brady M
    Parasit Vectors; 2015 Oct; 8():499. PubMed ID: 26427536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(29):989-91. PubMed ID: 21796097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urban lymphatic filariasis in the city of Tanga, Tanzania, after seven rounds of mass drug administration.
    Mwakitalu ME; Malecela MN; Pedersen EM; Mosha FW; Simonsen PE
    Acta Trop; 2013 Dec; 128(3):692-700. PubMed ID: 24135628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precontrol observations on lymphatic filariasis & geo-helminthiases in two coastal districts of rural Orrisa.
    Chhotray GP; Ranjit MR; Khuntia HK; Acharya AS
    Indian J Med Res; 2005 Nov; 122(5):388-94. PubMed ID: 16456251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic filariasis transmission risk map of India, based on a geo-environmental risk model.
    Sabesan S; Raju KH; Subramanian S; Srivastava PK; Jambulingam P
    Vector Borne Zoonotic Dis; 2013 Sep; 13(9):657-65. PubMed ID: 23808973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated morbidity mapping of lymphatic filariasis and podoconiosis cases in 20 co-endemic districts of Ethiopia.
    Kebede B; Martindale S; Mengistu B; Kebede B; Mengiste A; H/Kiros F; Tamiru A; Davey G; Kelly-Hope LA; Mackenzie CD
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006491. PubMed ID: 29965963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary mapping of lymphatic filariasis in Haiti-definition of transmission foci in low-prevalence settings.
    Drexler N; Washington CH; Lovegrove M; Grady C; Milord MD; Streit T; Lammie P
    PLoS Negl Trop Dis; 2012; 6(10):e1807. PubMed ID: 23071849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying filariasis and malaria control activities in relation to lymphatic filariasis elimination: a multiple intervention score map (MISM) for Malawi.
    Stanton MC; Mkwanda S; Mzilahowa T; Bockarie MJ; Kelly-Hope LA
    Trop Med Int Health; 2014 Feb; 19(2):224-35. PubMed ID: 24438053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.
    Chesnais CB; Awaca-Uvon NP; Bolay FK; Boussinesq M; Fischer PU; Gankpala L; Meite A; Missamou F; Pion SD; Weil GJ
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005703. PubMed ID: 28892473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated morbidity management for lymphatic filariasis and podoconiosis, Ethiopia.
    Deribe K; Kebede B; Tamiru M; Mengistu B; Kebede F; Martindale S; Sime H; Mulugeta A; Kebede B; Sileshi M; Mengiste A; McPherson S; Fentaye A
    Bull World Health Organ; 2017 Sep; 95(9):652-656. PubMed ID: 28867846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of lymphatic filariasis in India--a successful endeavour.
    Srivastava PK; Dhillon GP
    J Indian Med Assoc; 2008 Oct; 106(10):673-4, 676-7. PubMed ID: 19552103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
    Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.